Cargando…
Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
Myelodysplastic syndrome (MDS) refers to a heterogeneous group of closely related clonal hematopoietic disorders, which are characterized by accumulation of somatic mutations. The acquired mutation burden is suggested to define the pathway and consequent phenotype of the pathology. Recent studies ha...
Autores principales: | Bug, Dmitrii S., Tishkov, Artem V., Moiseev, Ivan S., Porozov, Yuri B., Petukhova, Natalia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471307/ https://www.ncbi.nlm.nih.gov/pubmed/34572006 http://dx.doi.org/10.3390/cells10092357 |
Ejemplares similares
-
Evaluating the Effect of 3′-UTR Variants in DICER1 and DROSHA on Their Tissue-Specific Expression by miRNA Target Prediction
por: Bug, Dmitrii S., et al.
Publicado: (2021) -
Identification and Characterization of a Novel CLCN7 Variant Associated with Osteopetrosis
por: Bug, Dmitrii S., et al.
Publicado: (2020) -
Emergence of an Auxin Sensing Domain in Plant-Associated Bacteria
por: Gavira, José A., et al.
Publicado: (2023) -
High mutation burden in the checkpoint and micro-RNA processing genes in myelodysplastic syndrome
por: Moiseev, Ivan Sergeevich, et al.
Publicado: (2021) -
Identification of platelet refractoriness in oncohematologic patients
por: Ferreira, Aline Aparecida, et al.
Publicado: (2011)